Smad3 null mice display more rapid wound closure and reduced scar formation after a stab wound to the cerebral cortex

Following central nervous system injury, adult mammalian neurons do not regenerate through regions of scar formation. This regenerative failure is due in part to the inhibitory environment of the glial scar at the lesion site. Following injury, transforming growth factor beta (TGF-beta) is strongly induced and is important to many aspects of the response to injury, including deposition of extracellular matrix (ECM) in the glial scar. However, the pathways through which TGF-beta signals to mediate these effects are not known. In order to examine the contribution of the TGF-beta-induced transcription factor, Smad3, to formation of the glial scar after traumatic brain injury, we utilized mice that do not express Smad3. We report that Smad3 null mice heal stab wounds to the cerebral cortex more rapidly than do wild-type mice. In Smad3 null mice many aspects of glial scar formation and the immune response to injury were altered. Fewer neutrophils, macrophages/microglia, NG2-positive cells and GFAP-positive cells were detected immediately around the lesion in Smad3 null mice. Expression of fibronectin and laminin was also reduced. Injury-induced cell proliferation was significantly lower in Smad3 null mice around the lesion. There was no overall difference between wild-type and Smad3 null mice in immunoreactivity for TGF-beta(1) after injury. Thus, our experiments suggest that TGF-beta signaling through Smad3 contributes significantly to the immune response and scar formation after cortical stab wound injury, delaying recovery through multiple mechanisms.

[1]  L M Wakefield,et al.  Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Massagué,et al.  Smad transcription factors. , 2005, Genes & development.

[3]  P. Hoodless,et al.  Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2. , 1998, Molecular cell.

[4]  G. Piras,et al.  A role for TGF-beta in oligodendrocyte differentiation , 1993, The Journal of cell biology.

[5]  Jack M Parent,et al.  Rat forebrain neurogenesis and striatal neuron replacement after focal stroke , 2002, Annals of neurology.

[6]  Stacey P. Memberg,et al.  Regeneration of adult axons in white matter tracts of the central nervous system , 1997, Nature.

[7]  M. Sporn,et al.  Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes , 1989, The Journal of cell biology.

[8]  J. Massagué,et al.  Transcriptional control by the TGF‐β/Smad signaling system , 2000 .

[9]  J. Massagué Integration of Smad and MAPK pathways: a link and a linker revisited. , 2003, Genes & development.

[10]  L. Mucke,et al.  Astroglial overproduction of TGF-β1 enhances inflammatory central nervous system disease in transgenic mice , 1997, Journal of Neuroimmunology.

[11]  W. Chambers,et al.  Inhibition of formation of a glial barrier as a means of permitting a peripheral nerve to grow into the brain , 1952, The Journal of comparative neurology.

[12]  James W. Fawcett,et al.  Chondroitinase ABC promotes functional recovery after spinal cord injury , 2002, Nature.

[13]  M. Sporn,et al.  Enhanced expression of transforming growth factor β1 in the rat brain after a localized cerebral injury , 1992, Brain Research.

[14]  C. Finch,et al.  Glial Fibrillary Acidic Protein Transcription Responses to Transforming Growth Factor‐β1 and Interleukin‐1β Are Mediated by a Nuclear Factor‐1‐Like Site in the Near‐Upstream Promoter , 1999, Journal of neurochemistry.

[15]  Kohei Miyazono,et al.  TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.

[16]  K. Miyazono,et al.  Identification of receptors and Smad proteins involved in activin signalling in a human epidermal keratinocyte cell line , 1998, Genes to cells : devoted to molecular & cellular mechanisms.

[17]  P. Hoodless,et al.  Smad2 Signaling in Extraembryonic Tissues Determines Anterior-Posterior Polarity of the Early Mouse Embryo , 1998, Cell.

[18]  R. Kucherlapati,et al.  Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Jeffrey L. Wrana,et al.  TGFβ signals through a heteromeric protein kinase receptor complex , 1992, Cell.

[20]  M. Sporn,et al.  Transforming Growth Factor‐&bgr;1 Reduces Infarct Size After Experimental Cerebral Ischemia in a Rabbit Model , 1993, Stroke.

[21]  James B. Graham,et al.  Regeneration of Axons after Nerve Transection Repair Is Enhanced by Degradation of Chondroitin Sulfate Proteoglycan , 2002, Experimental Neurology.

[22]  B. Trapp,et al.  NG2+ glial cells: a novel glial cell population in the adult brain. , 1999, Journal of neuropathology and experimental neurology.

[23]  J. Fawcett,et al.  Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC , 2001, Nature Neuroscience.

[24]  R. Derynck,et al.  SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS , 2005 .

[25]  J. Fawcett,et al.  Reduction in CNS scar formation without concomitant increase in axon regeneration following treatment of adult rat brain with a combination of antibodies to TGFβ1 and β2 , 2001, The European journal of neuroscience.

[26]  M. Pierre,et al.  Effects of transforming growth factor‐β1 on the extracellular matrix and cytoskeleton of cultured astrocytes , 1993 .

[27]  A. Logan,et al.  Expression of TGFβ2 but Not TGFβ1 Correlates with the Deposition of Scar Tissue in the Lesioned Spinal Cord , 2002, Molecular and Cellular Neuroscience.

[28]  H. Hartung,et al.  Microglia and macrophages are major sources of locally produced transforming growth factor‐β1 after transient middle cerebral artery occlusion in rats , 1998, Glia.

[29]  R. Kucherlapati,et al.  Functional Characterization of Transforming Growth Factor β Signaling in Smad2- and Smad3-deficient Fibroblasts* , 2001, The Journal of Biological Chemistry.

[30]  E. Li,et al.  Smad2 role in mesoderm formation, left–right patterning and craniofacial development , 1998, Nature.

[31]  R. Akhurst,et al.  Transforming growth factor βS: Biochemistry and biological activities in vitro and in vivo , 1996 .

[32]  I. Wickelgren Animal Studies Raise Hopes for Spinal Cord Repair , 2002, Science.

[33]  V. Gallo,et al.  Postnatal NG2 proteoglycan–expressing progenitor cells are intrinsically multipotent and generate functional neurons , 2003, The Journal of cell biology.

[34]  Guo-Yuan Yang,et al.  Reduction of Inflammatory Response in the Mouse Brain With Adenoviral-Mediated Transforming Growth Factor-&bgr;1 Expression , 2001, Stroke.

[35]  Ngan B. Doan,et al.  Reactive Astrocytes Protect Tissue and Preserve Function after Spinal Cord Injury , 2004, The Journal of Neuroscience.

[36]  M. Berry,et al.  Inhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor‐β2 , 1999, The European journal of neuroscience.

[37]  D. Kögel,et al.  TGF-β1 activates two distinct type I receptors in neurons , 2005, The Journal of Cell Biology.

[38]  J. Weiss,et al.  Astrocyte expression of monocyte chemoattractant protein-1 is differentially regulated by transforming growth factor beta , 1998, Journal of Neuroimmunology.

[39]  J. Schwab,et al.  Differential cellular accumulation of connective tissue growth factor defines a subset of reactive astrocytes, invading fibroblasts, and endothelial cells following central nervous system injury in rats and humans. , 2001, Journal of neurotrauma.

[40]  R. Berman,et al.  Early loss of astrocytes after experimental traumatic brain injury , 2003, Glia.

[41]  M. Sporn,et al.  Effects of Transforming Growth Factor β1, on Scar Production in the Injured Central Nervous System of the Rat , 1994 .

[42]  M. Sporn,et al.  Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells , 1986, The Journal of cell biology.

[43]  J. Silver,et al.  Injury-Induced Proteoglycans Inhibit the Potential for Laminin-Mediated Axon Growth on Astrocytic Scars , 1995, Experimental Neurology.

[44]  C. Culmsee,et al.  The expression of transforming growth factor-beta1 (TGF-β1) in hippocampal neurons: a temporary upregulated protein level after transient forebrain ischemia in the rat , 2000, Brain Research.

[45]  E. Schönherr,et al.  Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. , 1991, The Journal of biological chemistry.

[46]  P. Dijke,et al.  New insights into TGF-β–Smad signalling , 2004 .

[47]  E. Masliah,et al.  Loss of TGF-β1 Leads to Increased Neuronal Cell Death and Microgliosis in Mouse Brain , 2003, Neuron.

[48]  K. Khalili,et al.  Regulation of MCP-1 gene transcription by Smads and HIV-1 Tat in human glial cells. , 2003, Virology.

[49]  A. Nishiyama,et al.  Transient expression of the NG2 proteoglycan by a subpopulation of activated macrophages in an excitotoxic hippocampal lesion , 2001, Glia.

[50]  W. Vale,et al.  Roles of pathway-specific and inhibitory Smads in activin receptor signaling. , 1999, Molecular endocrinology.

[51]  J. Fawcett,et al.  Chondroitin sulphate proteoglycans in the CNS injury response. , 2002, Progress in brain research.

[52]  V. M. Neto,et al.  Glial fibrillary acidic protein gene promoter is differently modulated by transforming growth factor‐beta 1 in astrocytes from distinct brain regions , 2004, The European journal of neuroscience.

[53]  S. Gordon,et al.  Polymorphic expression of a neutrophil differentiation antigen revealed by monoclonal antibody 7/4 , 2004, Immunogenetics.

[54]  P. Gluckman,et al.  Neuronal rescue with transforming growth factor-beta 1 after hypoxic-ischaemic brain injury. , 1994, Neuroreport.

[55]  K. Flanders,et al.  Smad3 as a mediator of the fibrotic response , 2004, International journal of experimental pathology.

[56]  M. Sporn Growth factors and cytokines in health and disease , 1997 .

[57]  Clive N Svendsen,et al.  Leukocyte Infiltration, Neuronal Degeneration, and Neurite Outgrowth after Ablation of Scar-Forming, Reactive Astrocytes in Adult Transgenic Mice , 1999, Neuron.

[58]  T. Morgan,et al.  Expression of vimentin increases in the hippocampus and cerebral cortex after entorhinal cortex lesioning and in response to transforming growth factor β 1 , 1995, Journal of Neuroimmunology.

[59]  R. Brown,et al.  The effects of treatment with antibodies to transforming growth factor β1 and β2 following spinal cord damage in the adult rat , 2004, Neuroscience.

[60]  C. Abrass,et al.  bcn-1 Element-dependent Activation of the Laminin γ1 Chain Gene by the Cooperative Action of Transcription Factor E3 (TFE3) and Smad Proteins* , 2002, The Journal of Biological Chemistry.

[61]  J. Massagué,et al.  Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors , 1993, Cell.

[62]  Anita B. Roberts,et al.  Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response , 1999, Nature Cell Biology.

[63]  N. Thompson,et al.  Differential neuronal and astrocytic expression of transforming growth factor beta isoforms in rat hippocampus following transient forebrain ischemia. , 1996, Brain research. Molecular brain research.

[64]  Mark H. Tuszynski,et al.  NG2 Is a Major Chondroitin Sulfate Proteoglycan Produced after Spinal Cord Injury and Is Expressed by Macrophages and Oligodendrocyte Progenitors , 2002, The Journal of Neuroscience.

[65]  G. Alonso,et al.  NG2 proteoglycan‐expressing cells of the adult rat brain: Possible involvement in the formation of glial scar astrocytes following stab wound , 2005, Glia.

[66]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[67]  J. Levine,et al.  NG2: a component of the glial scar that inhibits axon growth , 2005, Journal of anatomy.

[68]  George M. Smith,et al.  Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes , 2005, Glia.

[69]  J. Silver,et al.  Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[70]  M. Berry,et al.  Decorin Attenuates Gliotic Scar Formation in the Rat Cerebral Hemisphere , 1999, Experimental Neurology.

[71]  Ying E. Zhang,et al.  Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.

[72]  Jerry Silver,et al.  Regeneration beyond the glial scar , 2004, Nature Reviews Neuroscience.

[73]  S. Davies,et al.  Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries , 2004, The European journal of neuroscience.

[74]  R. Derynck,et al.  Transcriptional Activators of TGF-β Responses: Smads , 1998, Cell.

[75]  V. Perry,et al.  Immunohistochemical localization of a macrophage-specific antigen in developing mouse retina: phagocytosis of dying neurons and differentiation of microglial cells to form a regular array in the plexiform layers , 1983, The Journal of cell biology.

[76]  X. F. Wang,et al.  Targeted Disruption of Smad3 Reveals an Essential Role in Transforming Growth Factor β-Mediated Signal Transduction , 1999, Molecular and Cellular Biology.

[77]  L. Mucke,et al.  Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-beta 1. , 1995, The American journal of pathology.

[78]  P. Henrich-Noack,et al.  TGF-beta 1 protects hippocampal neurons against degeneration caused by transient global ischemia. Dose-response relationship and potential neuroprotective mechanisms. , 1996, Stroke.

[79]  L. Acarín,et al.  Neuronal, astroglial and microglial cytokine expression after an excitotoxic lesion in the immature rat brain , 2000, The European journal of neuroscience.

[80]  M. Tuszynski,et al.  The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury , 2003, Experimental Neurology.

[81]  M. Pierre,et al.  Rapid TGFβ1 effects on actin cytoskeleton of astrocytes: Comparison with other factors and implications for cell motility , 1995, Glia.

[82]  J. Fawcett,et al.  Relationship between sprouting axons, proteoglycans and glial cells following unilateral nigrostriatal axotomy in the adult rat , 2002, Neuroscience.

[83]  J. Fawcett,et al.  The glial scar and central nervous system repair , 1999, Brain Research Bulletin.

[84]  S. K. Malhotra,et al.  Reactive astrocytes: cellular and molecular cues to biological function , 1997, Trends in Neurosciences.

[85]  J. Massagué,et al.  Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways , 1996, Nature.

[86]  A. Roberts,et al.  Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF‐β , 1999, The EMBO journal.

[87]  U. Lendahl,et al.  Abnormal Reaction to Central Nervous System Injury in Mice Lacking Glial Fibrillary Acidic Protein and Vimentin , 1999, The Journal of cell biology.